Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -3.90% | +2.78% | +4.23% |
04-04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
02-27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+4.23% | 14.34M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm : Achieves Full Enrolment for Part Two of NOXCOVID Trial; Shares Fall 3%